News Image

Ocugen To Present at BIO International Convention 2025

Provided By GlobeNewswire

Last update: Jun 11, 2025

MALVERN, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present at the 2025 BIO International Convention at the Boston Convention & Exhibition Center from June 16-19, 2025.

Read more at globenewswire.com

OCUGEN INC

NASDAQ:OCGN (7/25/2025, 8:13:16 PM)

After market: 1.08 -0.01 (-0.92%)

1.09

-0.03 (-2.68%)



Find more stocks in the Stock Screener

Follow ChartMill for more